Recent Publications on Infectious Diseases
Published on 18/05/2022
JPT offers a broad range of innovative peptide products that cover antigens of many known viruses and bacteria. With continuously emerging pathogens and their respective variants posing a threat to human and environmental health, we remain vigilant in providing the respective tools for vaccine development and antigen-specific immunotherapy, which can be applied in a multitude of studies:
- T-cell and B-cell epitope discovery
- Clinical trial immune monitoring
- Blood- and sero test development
- Cross-reactivity testing
- Cell therapy development of new potential vaccine delivery formats
Here we demonstrate the range of our catalog and customizable products on the basis of recent publications:
- Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient
Woldemeskel et al., Clinical Infectious Diseases (2022)
Keywords: SARS-CoV-2, mRNA Vaccine, clinical trial, Immune monitoring, omicron
Products used: PepMix SARS-CoV-2 (Spike Glycoprotein) & (Spike Omicron) - Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Peter et al., Molecular Therapy Methods (2022)
Keywords: SARS-CoV-2, Vaccine, Solid Organ Transplant, Tacrolimus, Immune Response
Products used: PepMix SARS-CoV-2 (Spike Glycoprotein SUB1 & SUB2), (VME1), (NCAP) (VEMP), (APA3), (NS7A), (NS7B), (ORF9B), (ORF10), (Spike Alpha), (Spike Beta), (Spike Delta), (Spike Omicron) - SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
Panikkar et al., PLoS Pathogens (2022)
Keywords: SARS-CoV-2 variants, adoptive immunotherapy, Immune Monitoring,
Products used: PepMix SARS-CoV-2 (NCAP), (APA3), (VME1), (Spike Glycoprotein) - SARS-CoV-2 mRNA vaccination fails to elicit humoral and cellular immune responses in multiple sclerosis patients receiving fingolimod
Meyer-Arndt et al., MedRxiv (2022)
Keywords: SARS-CoV-2 Vaccine, Humoral Immune Response, Multiple Sclerosis, Fingolimod
Product used: PepStar SARS-CoV-2 Spike Glycoprotein Variant Collection (incl. Omicron) - Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV
Wang et al., Vaccines (2022)
Keywords: HIV, AIDS, vaccine PDPHV, broadly binding & functional antibodies, B cells
Product used: PepStar HIV-1 env (gp120 protein + signal peptide) - Differential localization and limited cytotoxic potential of duodenal CD8+ T cells
Mvaya et al., JCI Insight (2022)
Keywords: HIV, duodenal tissue, CD8+ cells, increase cytotoxic potential of immunetherapy
Products used: PepMix HIV-1 (NEF) Ultra, (POL) Ultra, (GAG) Ultra - Direct Evidence for Viral Antigen Presentation during Latent Cytomegalovirus Infection
Lemmermann & Reddehase, Pathogens (2021)
Keywords: CMV, memory inflation, CD8+ T-cell response, viral latency
Product used: Custom Peptide Services
Check our website for more publications .
If we do not have your antigen of interest in stock, please check out our custom options or reach out to our customer support.